Institutional investors purchased a net $8.5 million shares of OPK during the quarter ended March 2018. This may signal that the smart money is gaining interest in this company as the 25.37% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 3.9 Million shares of OPKO Health Inc
MACKAY SHIELDS LLC Bought 2.8 Million shares of OPKO Health Inc
MILLENNIUM MANAGEMENT LLC Bought 1.6 Million shares of OPKO Health Inc